These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11243600)

  • 1. Introduction: utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents.
    Davidson MH
    Am J Cardiol; 2001 Feb; 87(4A):1A-7A. PubMed ID: 11243600
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk.
    Krauss RM
    Curr Opin Lipidol; 1994 Oct; 5(5):339-49. PubMed ID: 7858908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relationships of HDL- and LDL-cholesterol to cerebral infarction and to atherosclerosis--clinical and pathological study (author's transl)].
    Yamanouchi H; Tohgi H; Okabe H; Shimada H
    Nihon Ronen Igakkai Zasshi; 1981 May; 18(3):148-52. PubMed ID: 7289181
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipid lowering therapy in the treatment and secondary prevention of ischemic heart disease].
    Zimin IuV
    Kardiologiia; 2003; 43(4):74-83. PubMed ID: 12968608
    [No Abstract]   [Full Text] [Related]  

  • 5. [Structure and metabolism of plasma lipoproteins: effect of atherosclerosis].
    Fellin R
    G Ital Cardiol; 1976; 6(5):961-7. PubMed ID: 188709
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical results with gemfibrozil.
    Pickering JE
    Am J Cardiol; 1983 Aug; 52(4):39B-40B. PubMed ID: 6351579
    [No Abstract]   [Full Text] [Related]  

  • 7. ["Atherosclerosis-index" (LDL/HDL): risk indicator in lipid metabolism disorders].
    Mertz DP
    Med Klin; 1980 Feb; 75(4):159-61. PubMed ID: 7374617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes.
    Androulakis E; Zacharia E; Papageorgiou N; Lioudaki E; Bertsias D; Charakida M; Siasos G; Tousoulis D
    Curr Cardiol Rev; 2017; 13(3):168-182. PubMed ID: 28190386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of 5alpha-androstan-3beta, 17beta-diol on serum lipids and lipoproteins and the development of experimental atherosclerosis].
    Sharkevich IN
    Probl Endokrinol (Mosk); 1977; 23(4):99-104. PubMed ID: 198769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid pharmacotherapy for treatment of atherosclerosis.
    Nicholls SJ; Pisaniello AD; Kataoka Y; Puri R
    Expert Opin Pharmacother; 2014 Jun; 15(8):1119-25. PubMed ID: 24702590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What kinds of studies should be required to probe efficacy and safety of drugs in special populations?
    LaRosa JC; Sneider GB; Boyle C
    Am J Cardiol; 1998 Apr; 81(8A):84F-87F. PubMed ID: 9604921
    [No Abstract]   [Full Text] [Related]  

  • 12. Selected animal models for systematic antiatherosclerotic drug development.
    Day CE; Schurr PE; Phillips WA
    Adv Exp Med Biol; 1978; 109():277-83. PubMed ID: 215005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid disorders in type 2 diabetes.
    Laakso M
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():43-5. PubMed ID: 20629231
    [No Abstract]   [Full Text] [Related]  

  • 14. [HDL/LDL-cholesterol, arteriosclerosis and age (author's transl)].
    Richter V; Rassoul F; Senger H; Rotzsch W
    Z Alternsforsch; 1980; 35(5):359-64. PubMed ID: 7281727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The importance of cholesterol in high-density lipoproteins in determining risk for atherosclerosis].
    Brücknerová O
    Vnitr Lek; 1982 Jan; 28(1):15-22. PubMed ID: 7058632
    [No Abstract]   [Full Text] [Related]  

  • 16. Need for new classification of lipoprotein derangements in human atherosclerosis.
    Avogaro P; Bon GB; Cazzolato G
    Lancet; 1981 Jun; 1(8232):1257. PubMed ID: 6112580
    [No Abstract]   [Full Text] [Related]  

  • 17. LDL heterogeneity and atherosclerosis in nonhuman primates.
    Rudel LL; Bond MG; Bullock BC
    Ann N Y Acad Sci; 1985; 454():248-53. PubMed ID: 3865611
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipoproteins and arteriosclerosis].
    Shinomiya M; Morisaki N; Murano S; Sasaki N; Shirai K; Matsuoka N; Saito Y; Kumagai A
    Nihon Rinsho; 1980 Jul; 38(7):2798-814. PubMed ID: 7007691
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of Ziziphus spinosa Hu on serum lipoprotein and experimental atherosclerosis].
    Wu SX; Lang XC; Jia BY; Zhao SX; Li MX; Lan MY
    Zhongguo Zhong Yao Za Zhi; 1989 Jul; 14(7):434-51, 448. PubMed ID: 2610883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rediscovery of high density lipoprotein: a negative risk factor in atherosclerosis.
    Steinberg D
    Eur J Clin Invest; 1978 Jun; 8(3):107-9. PubMed ID: 211033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.